98 related articles for article (PubMed ID: 16808998)
21. Co-expression of mu and delta opioid receptors as receptor-G protein fusions enhances both mu and delta signalling via distinct mechanisms.
Snook LA; Milligan G; Kieffer BL; Massotte D
J Neurochem; 2008 May; 105(3):865-73. PubMed ID: 18182056
[TBL] [Abstract][Full Text] [Related]
22. Functional reduction in mu-opioidergic system in the spinal cord under a neuropathic pain-like state following chronic ethanol consumption in the rat.
Narita M; Miyoshi K; Narita M; Suzuki T
Neuroscience; 2007 Feb; 144(3):777-82. PubMed ID: 17156932
[TBL] [Abstract][Full Text] [Related]
23. Antiexudative effects of opioids and expression of kappa- and delta-opioid receptors during intestinal inflammation in mice: involvement of nitric oxide.
Jiménez N; Puig MM; Pol O
J Pharmacol Exp Ther; 2006 Jan; 316(1):261-70. PubMed ID: 16183704
[TBL] [Abstract][Full Text] [Related]
24. The role of reactive oxygen species in morphine addiction of SH-SY5Y cells.
Ma J; Yuan X; Qu H; Zhang J; Wang D; Sun X; Zheng Q
Life Sci; 2015 Mar; 124():128-35. PubMed ID: 25623851
[TBL] [Abstract][Full Text] [Related]
25. Agonist-specific down regulation of mu-opioid receptors: Different cellular pathways are activated by different opioid agonists.
Binyaminy B; Gafni M; Shapira M; Sarne Y
Life Sci; 2008 Apr; 82(15-16):831-9. PubMed ID: 18358497
[TBL] [Abstract][Full Text] [Related]
26. Effects of mu-opioid receptor modulation on GABAB receptor synaptic function in hippocampal CA1.
McQuiston AR
J Neurophysiol; 2007 Mar; 97(3):2301-11. PubMed ID: 17215502
[TBL] [Abstract][Full Text] [Related]
27. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
[TBL] [Abstract][Full Text] [Related]
28. In vivo evaluation of (+)-MR200 as a new selective sigma ligand modulating MOP, DOP and KOP supraspinal analgesia.
Marrazzo A; Parenti C; Scavo V; Ronsisvalle S; Scoto GM; Ronsisvalle G
Life Sci; 2006 Apr; 78(21):2449-53. PubMed ID: 16324720
[TBL] [Abstract][Full Text] [Related]
29. Effect of agmatine on DAMGO-induced mu-opioid receptor down-regulation and internalization via activation of IRAS, a candidate for imidazoline I(1) receptor.
Gao Y; Li F; Wu N; Su RB; Liu Y; Lu XQ; Liu Y; Li J
Eur J Pharmacol; 2008 Dec; 599(1-3):18-23. PubMed ID: 18845140
[TBL] [Abstract][Full Text] [Related]
30. DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens.
Al-Khrasani M; Spetea M; Friedmann T; Riba P; Király K; Schmidhammer H; Furst S
Brain Res Bull; 2007 Oct; 74(5):369-75. PubMed ID: 17845912
[TBL] [Abstract][Full Text] [Related]
31. The mu-opioid receptor subtype is required for the anorectic effect of an opioid receptor antagonist.
Zhang J; Frassetto A; Huang RR; Lao JZ; Pasternak A; Wang SP; Metzger JM; Strack AM; Fong TM; Chen RZ
Eur J Pharmacol; 2006 Sep; 545(2-3):147-52. PubMed ID: 16876155
[TBL] [Abstract][Full Text] [Related]
32. Delta receptors are required for full inhibitory coupling of mu-receptors to voltage-dependent Ca(2+) channels in dorsal root ganglion neurons.
Walwyn W; John S; Maga M; Evans CJ; Hales TG
Mol Pharmacol; 2009 Jul; 76(1):134-43. PubMed ID: 19357247
[TBL] [Abstract][Full Text] [Related]
33. Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists.
Miller DK; Lever JR; Rodvelt KR; Baskett JA; Will MJ; Kracke GR
Drug Alcohol Depend; 2007 Jul; 89(2-3):282-91. PubMed ID: 17368966
[TBL] [Abstract][Full Text] [Related]
34. Activation of mu-opioid receptor selectively potentiates NMDA-induced outward currents in rat locus coeruleus neurons.
Koyama S; Akaike N
Neurosci Res; 2008 Jan; 60(1):22-8. PubMed ID: 17976846
[TBL] [Abstract][Full Text] [Related]
35. Anti-opioid activities of NPFF1 receptors in a SH-SY5Y model.
Kersanté F; Mollereau C; Zajac JM; Roumy M
Peptides; 2006 May; 27(5):980-9. PubMed ID: 16488058
[TBL] [Abstract][Full Text] [Related]
36. Methamphetamine-mediated modulation of MOR expression in the SH-SY5Y neuroblastoma cell line.
Langsdorf EF; Chang SL
Synapse; 2011 Sep; 65(9):858-65. PubMed ID: 21308796
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance.
Zhao M; Joo DT
Anesthesiology; 2008 Aug; 109(2):308-17. PubMed ID: 18648240
[TBL] [Abstract][Full Text] [Related]
38. Mu opioid receptor mutant, T394A, abolishes opioid-mediated adenylyl cyclase superactivation.
Wang H; Guang W; Barbier E; Shapiro P; Wang JB
Neuroreport; 2007 Dec; 18(18):1969-73. PubMed ID: 18007196
[TBL] [Abstract][Full Text] [Related]
39. Rapid modulation of micro-opioid receptor signaling in primary sensory neurons.
Berg KA; Patwardhan AM; Sanchez TA; Silva YM; Hargreaves KM; Clarke WP
J Pharmacol Exp Ther; 2007 Jun; 321(3):839-47. PubMed ID: 17347322
[TBL] [Abstract][Full Text] [Related]
40. Co-localization of mu and delta opioid receptors on SK-N-SH cells detected by fluorescence microscopy using labeled anti-idiotypic antibodies.
Agarwal D; Glasel JA
Life Sci; 1993; 52(18):PL193-8. PubMed ID: 8387131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
